Inovio Pharmaceuticals, Inc.
INO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$45 | -$23,519 | -$20 | -$19 |
| Dep. & Amort. | $1 | $742 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1 | $835 | $1 | $1 |
| Change in WC | -$1 | $0 | -$5 | -$1 |
| Other Non-Cash | $23 | $1,131 | -$5 | -$2 |
| Operating Cash Flow | -$22 | -$20,811 | -$27 | -$20 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$4,946 | $0 | $0 |
| Inv. Sales/Matur. | $9 | $10,967 | $0 | $35 |
| Other Inv. Act. | $0 | -$738 | $0 | $0 |
| Investing Cash Flow | $9 | $5,282 | -$0 | $35 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $7 | $0 | $1 | $13 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $18 | -$35 | -$0 | $16 |
| Financing Cash Flow | $25 | -$35 | $1 | $29 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $12 | -$15,564 | -$26 | $44 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $24 | $39,915 | $66 | $22 |
| End Cash | $37 | $24,351 | $40 | $66 |
| Free Cash Flow | -$22 | -$20,811 | -$27 | -$20 |